LOGIN  |  REGISTER
Assertio

Recent Insider Transactions - Syros Pharmaceuticals (NASDAQ: SYRS)

Follow NASDAQ:SYRS Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SYRS Syros Pharmaceuticals
Stephens Kristin / officer: Chief Development Officer
11/18/2024
Sell
$0.22
36,133
$8K
0
NASDAQ SYRS Syros Pharmaceuticals
Roth David / officer: Chief Medical Officer
11/18/2024
Sell
$0.20
12,099
$2K
0
NASDAQ SYRS Syros Pharmaceuticals
Quirk Gerald E / officer: Chief Legal & Compliance Offic
11/19/2024
Sell
$0.22
46,657
$10K
0
NASDAQ SYRS Syros Pharmaceuticals
Chee Conley / director, officer: President & CEO
11/18/2024
Sell
$0.20
134,797
$27K
0
NASDAQ SYRS Syros Pharmaceuticals
Haas Jason / officer: Chief Financial Officer
11/18/2024
Sell
$0.21
137,803
$29K
0
NASDAQ SYRS Syros Pharmaceuticals
Roth David / officer: Chief Medical Officer
10/31/2024
Sell
$2.09
6,776
$14K
12,099
NASDAQ SYRS Syros Pharmaceuticals
Haas Jason / officer: Chief Financial Officer
10/31/2024
Sell
$2.09
5,624
$12K
137,803
NASDAQ SYRS Syros Pharmaceuticals
Chee Conley / director, officer: President & CEO
10/31/2024
Sell
$2.09
8,707
$18K
130,797
NASDAQ SYRS Syros Pharmaceuticals
Stephens Kristin / officer: Chief Development Officer
10/31/2024
Sell
$2.09
6,104
$13K
36,133
NASDAQ SYRS Syros Pharmaceuticals
Quirk Gerald E / officer: Chief Legal & Compliance Offic
09/30/2024
Sell
$2.10
3,100
$7K
46,657

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous